CONCORDANCE IN PERCEPTIONS OF THE IMPACT OF SUBCUTANEOUS BELIMUMAB TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS BETWEEN PATIENTS AND THEIR PHYSICIANS: A CROSS-SECTIONAL, REAL-WORLD SURVEY
REAL-WORLD EXPERIENCE OF SUBCUTANEOUS BELIMUMAB TREATMENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL SURVEY OF RHEUMATOLOGISTS AND THEIR PATIENTS